425 related articles for article (PubMed ID: 27903803)
21. Novel real-time monitoring system for human cytomegalovirus-infected cells in vitro that uses a green fluorescent protein-PML-expressing cell line.
Ueno T; Eizuru Y; Katano H; Kurata T; Sata T; Irie S; Ogawa-Goto K
Antimicrob Agents Chemother; 2006 Aug; 50(8):2806-13. PubMed ID: 16870775
[TBL] [Abstract][Full Text] [Related]
22. SUMOylation of the human cytomegalovirus 72-kilodalton IE1 protein facilitates expression of the 86-kilodalton IE2 protein and promotes viral replication.
Nevels M; Brune W; Shenk T
J Virol; 2004 Jul; 78(14):7803-12. PubMed ID: 15220454
[TBL] [Abstract][Full Text] [Related]
23. The major immediate-early proteins IE1 and IE2 of human cytomegalovirus colocalize with and disrupt PML-associated nuclear bodies at very early times in infected permissive cells.
Ahn JH; Hayward GS
J Virol; 1997 Jun; 71(6):4599-613. PubMed ID: 9151854
[TBL] [Abstract][Full Text] [Related]
24. Positive role of promyelocytic leukemia protein in type I interferon response and its regulation by human cytomegalovirus.
Kim YE; Ahn JH
PLoS Pathog; 2015 Mar; 11(3):e1004785. PubMed ID: 25812002
[TBL] [Abstract][Full Text] [Related]
25. Inhibiting ubiquitination causes an accumulation of SUMOylated newly synthesized nuclear proteins at PML bodies.
Sha Z; Blyszcz T; González-Prieto R; Vertegaal ACO; Goldberg AL
J Biol Chem; 2019 Oct; 294(42):15218-15234. PubMed ID: 31285264
[TBL] [Abstract][Full Text] [Related]
26. SUMOylation regulates the number and size of promyelocytic leukemia-nuclear bodies (PML-NBs) and arsenic perturbs SUMO dynamics on PML by insolubilizing PML in THP-1 cells.
Hirano S; Udagawa O
Arch Toxicol; 2022 Feb; 96(2):545-558. PubMed ID: 35001170
[TBL] [Abstract][Full Text] [Related]
27. NS5 Sumoylation Directs Nuclear Responses That Permit Zika Virus To Persistently Infect Human Brain Microvascular Endothelial Cells.
Conde JN; Schutt WR; Mladinich M; Sohn SY; Hearing P; Mackow ER
J Virol; 2020 Sep; 94(19):. PubMed ID: 32699085
[TBL] [Abstract][Full Text] [Related]
28. Role of SUMO in RNF4-mediated promyelocytic leukemia protein (PML) degradation: sumoylation of PML and phospho-switch control of its SUMO binding domain dissected in living cells.
Percherancier Y; Germain-Desprez D; Galisson F; Mascle XH; Dianoux L; Estephan P; Chelbi-Alix MK; Aubry M
J Biol Chem; 2009 Jun; 284(24):16595-16608. PubMed ID: 19380586
[TBL] [Abstract][Full Text] [Related]
29. Characterization of human herpesvirus 6 variant B immediate-early 1 protein modifications by small ubiquitin-related modifiers.
Gravel A; Dion V; Cloutier N; Gosselin J; Flamand L
J Gen Virol; 2004 May; 85(Pt 5):1319-1328. PubMed ID: 15105549
[TBL] [Abstract][Full Text] [Related]
30. SUMO5, a Novel Poly-SUMO Isoform, Regulates PML Nuclear Bodies.
Liang YC; Lee CC; Yao YL; Lai CC; Schmitz ML; Yang WM
Sci Rep; 2016 May; 6():26509. PubMed ID: 27211601
[TBL] [Abstract][Full Text] [Related]
31. Viral immediate-early proteins abrogate the modification by SUMO-1 of PML and Sp100 proteins, correlating with nuclear body disruption.
Müller S; Dejean A
J Virol; 1999 Jun; 73(6):5137-43. PubMed ID: 10233977
[TBL] [Abstract][Full Text] [Related]
32. Human Regulatory Protein Ki-1/57 Is a Target of SUMOylation and Affects PML Nuclear Body Formation.
Saito Â; Souza EE; Costa FC; Meirelles GV; Gonçalves KA; Santos MT; Bressan GC; McComb ME; Costello CE; Whelan SA; Kobarg J
J Proteome Res; 2017 Sep; 16(9):3147-3157. PubMed ID: 28695742
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of interactions of human cytomegalovirus immediate-early IE2 regulatory protein with small ubiquitin-like modifiers and their conjugation enzyme Ubc9.
Ahn JH; Xu Y; Jang WJ; Matunis MJ; Hayward GS
J Virol; 2001 Apr; 75(8):3859-72. PubMed ID: 11264375
[TBL] [Abstract][Full Text] [Related]
34. SUMO-1 modification of human cytomegalovirus IE1/IE72.
Spengler ML; Kurapatwinski K; Black AR; Azizkhan-Clifford J
J Virol; 2002 Mar; 76(6):2990-6. PubMed ID: 11861864
[TBL] [Abstract][Full Text] [Related]
35. The Promyelocytic Leukemia Protein facilitates human herpesvirus 6B chromosomal integration, immediate-early 1 protein multiSUMOylation and its localization at telomeres.
Collin V; Gravel A; Kaufer BB; Flamand L
PLoS Pathog; 2020 Jul; 16(7):e1008683. PubMed ID: 32658923
[TBL] [Abstract][Full Text] [Related]
36. MORC3 restricts human cytomegalovirus infection by suppressing the major immediate-early promoter activity.
Ma XH; Yao YX; Wang XZ; Zhou YP; Huang SN; Li D; Mei MJ; Wu JP; Pan YT; Cheng S; Jiang X; Sun JY; Zeng WB; Gong S; Cheng H; Luo MH; Yang B
J Med Virol; 2022 Nov; 94(11):5492-5506. PubMed ID: 35879101
[TBL] [Abstract][Full Text] [Related]
37. Non-covalent Interaction With SUMO Enhances the Activity of Human Cytomegalovirus Protein IE1.
Tripathi V; Chatterjee KS; Das R
Front Cell Dev Biol; 2021; 9():662522. PubMed ID: 34055792
[TBL] [Abstract][Full Text] [Related]
38. SUMOylation promotes PML degradation during encephalomyocarditis virus infection.
El McHichi B; Regad T; Maroui MA; Rodriguez MS; Aminev A; Gerbaud S; Escriou N; Dianoux L; Chelbi-Alix MK
J Virol; 2010 Nov; 84(22):11634-45. PubMed ID: 20826694
[TBL] [Abstract][Full Text] [Related]
39. Swine Promyelocytic Leukemia Isoform II Inhibits Pseudorabies Virus Infection by Suppressing Viral Gene Transcription in Promyelocytic Leukemia Nuclear Bodies.
Yu C; Xu A; Lang Y; Qin C; Wang M; Yuan X; Sun S; Feng W; Gao C; Chen J; Zhang R; Tang J
J Virol; 2020 Aug; 94(18):. PubMed ID: 32641476
[TBL] [Abstract][Full Text] [Related]
40. General blockade of human cytomegalovirus immediate-early mRNA expression in the S/G2 phase by a nuclear, Daxx- and PML-independent mechanism.
Zydek M; Uecker R; Tavalai N; Stamminger T; Hagemeier C; Wiebusch L
J Gen Virol; 2011 Dec; 92(Pt 12):2757-2769. PubMed ID: 21832009
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
